Legal Representation
Attorney
KLAUS P. STOFFEL
USPTO Deadlines
Next Deadline
1980 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-10)
Due Date
December 10, 2030
Grace Period Ends
June 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 eventsDate | Code | Type | Description |
---|---|---|---|
Dec 10, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Dec 10, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Oct 8, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Oct 8, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
Sep 18, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Sep 4, 2024 | EXPT | T | EXPARTE APPEAL TERMINATED |
Sep 4, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Sep 4, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Sep 4, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Sep 4, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Sep 4, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Sep 4, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jul 1, 2024 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
Jul 1, 2024 | GNSF | O | SUBSEQUENT FINAL EMAILED |
Jul 1, 2024 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN |
Jun 4, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Jun 4, 2024 | EXPI | T | EX PARTE APPEAL-INSTITUTED |
Jun 4, 2024 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB |
Jun 4, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Mar 4, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Mar 4, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Dec 4, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
Dec 4, 2023 | GNFR | O | FINAL REFUSAL E-MAILED |
Dec 4, 2023 | CNFR | R | FINAL REFUSAL WRITTEN |
Sep 21, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Sep 20, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sep 20, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jun 19, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Jun 19, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Mar 20, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Mar 20, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
Mar 20, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
Mar 1, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Apr 27, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 26, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Oils and fats, namely, lipids used in the manufacture of cosmetics, beverages, food products, pharmaceuticals and dietary supplements for the manufacture of pharmaceuticals, medical and veterinary preparations, sanitary preparations for medical purposes, dietetic foodstuffs and products for medical or veterinary purposes, food supplements for humans and animals, medicines and natural remedies, dietetic preparations and food supplements and pharmaceutical preparations and substances, dietary supplements and dietetic preparations, food for babies and infants, and for manufacturing beverages for infants and infant formula; any cannabis or cannabis derived ingredients in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing containing cannabidiol (CBD)
Class 005
Pharmaceutical, medical and veterinary preparations, namely, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, and chemical reagents for medical or veterinary purposes, chemical reagents for medical or veterinary purposes; sanitary preparations for medical purposes; dietetic foodstuffs and goods for medical or veterinary purposes, namely, dietetic foods and beverages adapted for medical use, dietetic foods adapted for veterinary use, dietetic beverages adapted for veterinary use, and dietetic preparations adapted for medical purposes; food supplements for humans and animals; disinfectants; medicines and natural remedies, namely medicinal oils and antiallergic medicines, medicinal preparations for the treatment of infectious diseases and for use in oncology, medicinal drinks, medicinal preparations for infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, for the prevention and treatment of cancer, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria- based diseases, for the treatment of epilepsy, pain, anxiety, depression, sleep disorders, Parkinson's disease, nausea and vomiting, food disorders, arthritis, PTSD, schizophrenia, opioid addiction, alleviate ALS symptoms, multiple sclerosis, and for the treatment of diabetes, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; dietetic preparations, namely Dietetic preparations adapted for medical purposes; food supplements; food for babies; food for infants; infant formula; any cannabis or cannabis derived ingredients in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing containing cannabidiol (CBD)
Class 029
Oils and fats, namely edible oils and edible fats and oils and fats for food; dietetic oils and fats in the nature of edible oils and fats, not for medical purposes; any cannabis or cannabis derived ingredients in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing containing cannabidiol (CBD)
Classification
International Classes
001
005
029
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"